NTBL: Notable Labs Corp Market Capitalization

The market valuation chart for Notable Labs, Ltd. (NTBL) demonstrates a capitalization of 0.00. The business focuses on creating personalized cancer treatment regimens by selecting optimal medications through the analysis of a patient's live cells. Development relies on a team of visionaries and IT specialists working remotely. Meanwhile, Notable Labs, Ltd. (NTBL) minimizes infrastructure costs by outsourcing routine tests to third-party contractors while retaining key patents.

NTBL notablelabs.com: Market Value in the range 02/21/2024 - 11/02/2024

Market capitalization determines the aggregate value of all an issuer's shares, serving as an indicator of investment confidence. The dynamics of a business's market capitalization demonstrate the balance of supply and demand, which is critical for asset indexing. This metric is calculated as the product of the current share price and the total number of outstanding shares. For Notable Labs, Ltd. (NTBL), this figure reflects the market valuation of the scaling potential of its IT platform for selecting oncology drugs. The increase in value confirms the success of its expansion into the B2B contract segment with biopharmaceuticals.

Competitors of Notable Labs, Ltd. (NTBL)

BeiGene - Market Valuation|Market Value HALO (Halozyme Therapeutics, Inc.)|RevMed - Market Capitalization|AAPG: Market Value|CG Oncology, Inc. (CGON) - Market Value|URGN (urogen.com) - Market Value|BCAX (Bicara Therapeutics) - Market Capitalization|Market Valuation Personalis Inc (PSNL)|Market Capitalization ERAS|Market Capitalization Delcath Corp (DCTH)|Market Value Y-mAbs Therapeutics YMAB|AURA: Market Capitalization|Candel - Market Capitalization|Accuray Inc (ARAY) - Market Valuation|SLS: Market Capitalization|Market Value Actuate Therapeutics Inc (ACTU)|Market Value Citius Oncology, Inc.|HURA: Market Value|Market Valuation TARA (Protara Therapeutics, Inc.)|FATE (Fate Therapeutics Inc) - Market Value|Market Capitalization WHWK (Aadi Bioscience)|TCRX - Market Valuation|CSBR: Market Valuation|XBIT - Market Capitalization|cel-sci.com (CVM) - Market Value|OS Therapies Inc. - Market Value|RADX (Radiopharm Theranostics) - Market Capitalization|Market Value Artiva ARTV|Market Value Adlai Nortye Ltd. (ANL)|verupharma.com - Market Capitalization|Market Value Tempest Therapeutics, Inc. TPST|Xilio Therapeutics Inc (XLO) - Market Value|RENB: Market Valuation|Mural Oncology plc - Market Value|KAPA: Market Capitalization|OnKure Therapeutics (OKUR) - Market Capitalization|GDTC (CytoMed Therapeutics Ltd) - Market Capitalization|Market Value CRIS|Market Value Apollomics, Inc. (APLM)|Market Value THAR (Tharimmune Corporation)|Market Capitalization ADVB (Advanced Biomed)|genprex.com (GNPX) - Market Value|CLDI: Market Valuation|Market Value SBFM (sunshinebiopharma.com)|xeneticbio.com (XBIO) - Market Value|SLRX (Salarius Pharma) - Market Value|PPBT (Purple Biotech) - Market Capitalization|Market Capitalization AON|Market Capitalization BGNE|Market Value CKPT (Checkpoint Therapeutics Inc.)|Market Value Elevation Oncology ELEV|Market Capitalization iCAD Inc. (ICAD)|IKNA: Market Valuation|Market Value VIRX (Viracta Therapeutics)|MorphoSys (MOR) - Market Value|NAYA (NAYA Biosciences Inc) - Market Value|Market Valuation AAPGV